BIOMAT Database Logo BIOMAT Database Logo

Pharmacokinetics of zidovudine phosphorylation in human immunodeficiency virus-positive thai patients and healthy volunteers. 2000

Y Wattanagoon, and K Na Bangchang, and P G Hoggard, and S H Khoo, and S E Gibbons, and D Phiboonbhanakit, and J Karbwang, and D J Back
Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

We assessed the pharmacokinetics of zidovudine (ZDV) in plasma and intracellular ZDV phosphate anabolites in peripheral blood mononuclear cells in Thai human immunodeficiency virus (HIV) type 1-infected patients and healthy volunteers. The plasma ZDV area under the concentration-time curve from 0 to 6 h (AUC(0-6)) was similar in patients and healthy volunteers (32.77 and 22.77 micromol/liter. h, respectively; confidence interval, -3.37 to 19. 92). Although the concentration of ZDV triphosphate (ZDVTP) was similar in the two groups, the ZDV monophosphate (ZDVMP) AUC(0-6) was significantly greater in HIV patients (1.12 pmol/10(6) cells) than in healthy volunteers (0.15 pmol/10(6) cells). In agreement with previously published data obtained with Caucasians, the significant difference in intracellular phosphorylation in Thai volunteers and HIV patients is primarily due to ZDVMP. Comparing the data from this study with the data obtained with Caucasians suggests no marked ethnic differences in ZDV phosphorylation.

UI MeSH Term Description Entries
D008297 Male Males
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013785 Thailand Formerly known as Siam, this is a Southeast Asian nation at the center of the Indochina peninsula. Bangkok is the capital city. Kingdom of Thailand,Siam
D013942 Thymine Nucleotides Phosphate esters of THYMIDINE in N-glycosidic linkage with ribose or deoxyribose, as occurs in nucleic acids. (From Dorland, 28th ed, p1154) Thymidine Phosphates,Nucleotides, Thymine,Phosphates, Thymidine
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D054306 Dideoxynucleotides The phosphate esters of DIDEOXYNUCLEOSIDES. Dideoxynucleotide Triphosphates,ddNTPs,Triphosphates, Dideoxynucleotide

Related Publications

Y Wattanagoon, and K Na Bangchang, and P G Hoggard, and S H Khoo, and S E Gibbons, and D Phiboonbhanakit, and J Karbwang, and D J Back
Pharmacokinetics of zidovudine phosphorylation in patients infected with the human immunodeficiency virus.
August 1992, Therapeutic drug monitoring,
Y Wattanagoon, and K Na Bangchang, and P G Hoggard, and S H Khoo, and S E Gibbons, and D Phiboonbhanakit, and J Karbwang, and D J Back
Pharmacokinetics of zidovudine phosphorylation in peripheral blood mononuclear cells from patients infected with human immunodeficiency virus.
July 1994, Antimicrobial agents and chemotherapy,
Y Wattanagoon, and K Na Bangchang, and P G Hoggard, and S H Khoo, and S E Gibbons, and D Phiboonbhanakit, and J Karbwang, and D J Back
Multidose pharmacokinetics of ritonavir and zidovudine in human immunodeficiency virus-infected patients.
July 1998, Antimicrobial agents and chemotherapy,
Y Wattanagoon, and K Na Bangchang, and P G Hoggard, and S H Khoo, and S E Gibbons, and D Phiboonbhanakit, and J Karbwang, and D J Back
Pharmacokinetics of sirolimus in Thai healthy volunteers.
September 2005, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
Y Wattanagoon, and K Na Bangchang, and P G Hoggard, and S H Khoo, and S E Gibbons, and D Phiboonbhanakit, and J Karbwang, and D J Back
Pharmacokinetics of halofantrine in healthy Thai volunteers.
November 1991, British journal of clinical pharmacology,
Y Wattanagoon, and K Na Bangchang, and P G Hoggard, and S H Khoo, and S E Gibbons, and D Phiboonbhanakit, and J Karbwang, and D J Back
Pharmacokinetics of zidovudine after rectal administration in human immunodeficiency virus-infected patients.
May 1997, Antimicrobial agents and chemotherapy,
Y Wattanagoon, and K Na Bangchang, and P G Hoggard, and S H Khoo, and S E Gibbons, and D Phiboonbhanakit, and J Karbwang, and D J Back
Pharmacokinetics of levofloxacin in healthy Thai male volunteers.
November 1999, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
Y Wattanagoon, and K Na Bangchang, and P G Hoggard, and S H Khoo, and S E Gibbons, and D Phiboonbhanakit, and J Karbwang, and D J Back
Pharmacokinetics of prophylactic mefloquine in Thai healthy volunteers.
March 1991, The Southeast Asian journal of tropical medicine and public health,
Y Wattanagoon, and K Na Bangchang, and P G Hoggard, and S H Khoo, and S E Gibbons, and D Phiboonbhanakit, and J Karbwang, and D J Back
Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus.
May 1994, The Journal of infectious diseases,
Y Wattanagoon, and K Na Bangchang, and P G Hoggard, and S H Khoo, and S E Gibbons, and D Phiboonbhanakit, and J Karbwang, and D J Back
Zidovudine improves psoriasis in human immunodeficiency virus-positive males.
April 1994, Archives of dermatology,
Copied contents to your clipboard!